Historic $7.4 Billion Settlement in Opioid Crisis
Attorneys general from all U.S. states, D.C., and territories have reached a $7.4 billion settlement with Purdue Pharma to address lawsuits accusing the company of fueling the opioid crisis through its drug OxyContin. The Sackler family, Purdue's owners, have agreed to finalize this significant agreement.
In a groundbreaking agreement, attorneys general from all 50 U.S. states, Washington, D.C., and four territories have secured a $7.4 billion settlement with the bankrupt pharmaceutical giant Purdue Pharma. The deal aims to conclude numerous lawsuits that blame the company's OxyContin painkiller for exacerbating the nationwide opioid addiction crisis.
New Jersey Attorney General Matthew Platkin revealed that members of the Sackler family, who own Purdue, have confirmed their commitment to moving forward with the settlement. The development marks a pivotal moment in holding pharmaceutical companies accountable for their role in the opioid epidemic.
The settlement is expected to provide significant resources to address opioid addiction, prevention, and recovery programs across the nation, as the states and affected regions work to combat the epidemic's devastating impact on communities.
(With inputs from agencies.)
Google News